Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session



  • Sono Group N.V. SEV shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
  • Forza X1, Inc. FRZA shares jumped 94.3% to $2.4299 after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'
  • Chijet Motor Company, Inc. CJET shares gained 73% to $6.63 after dipping around 33% on Friday. The stock is experiencing an upward trend in trading Monday, driven by post-IPO volatility subsequent to its debut listing on the NASDAQ on Friday.
  • CIRCOR International, Inc. CIR surged 50.1% to $47.54 after the company announced an agreement to be acquired by KKR for $49 per share in cash.
  • Regencell Bioscience Holdings Limited RGC gained 35.5% to $30.49.
  • Timber Pharmaceuticals, Inc. TMBR rose 35% to $2.0139 following a positive decision from the FDA for its TMB-001 treatment.
  • Pasithea Therapeutics Corp. KTTA climbed 30.8% to $0.5232. Lucy Scientific Discovery announced proposal to acquire Pasithea Therapeutics for $0.60 per share in cash and $0.25 per share in Lucy stock.
  • Dunxin Financial Holdings Limited DXF gained 29.9% to $0.2671after gaining over 15% on Friday.
  • InnSuites Hospitality Trust IHT surged 27.3% to $3.0040.
  • National CineMedia, Inc. NCMI gained 27% to $0.38. National CineMedia announced new long-term advertising agreement with Regal Cinemas.
  • CXApp Inc. CXAI rose 23.7% to $12.35.
  • Coeptis Therapeutics Holdings, Inc. COEP surged 20% to $1.8238.
  • Journey Medical Corporation DERM gained 20% to $1.50.
  • CURO Group Holdings Corp. CURO rose 18.8% to $1.8297.
  • BiondVax Pharmaceuticals Ltd. BVXV gained 17.7% to $2.0249 after the company signed a worldwide license agreement to develop an antibody for treatment of autoimmune and inflammatory diseases.
  • Getty Images Holdings, Inc. GETY climbed 15.5% to $5.50.
  • WeWork Inc. WE gained 14.7% to $0.2123.
  • Replimune Group, Inc. REPL rose 14.6% to $21.77. Replimune presented RP1 data from the IGNYTE anti-PD1 failed melanoma cohort and RP2 Data in uveal melanoma at the ASCO.
  • TOP Financial Group Limited TOP surged 14.3% to $8.21.
  • Amedisys, Inc. AMED gained 14.2% to $90.79 after the company received an unsolicited proposal from Optum for $100 per share.
  • Blue Apron Holdings, Inc. APRN rose 14.1% to $0.6047.
  • Scilex Holding Company SCLX jumped 12.6% to $7.22.
  • Day One Biopharmaceuticals, Inc. DAWN gained 11.8% to $15.22 after the company announced overall response rate of 67% and clinical benefit rate of 93% in 69 heavily pretreated RANO-HGG evaluable patients in pediatric low-grade glioma trial.
  • Kaspien Holdings Inc. KSPN shares climbed 11.8% to $0.3316. Kaspien recently announced a voluntary delisting from The Nasdaq Capital Market.
  • Bowlero Corp. BOWL rose 11% to $12.88. Stifel maintained Bowlero with a Buy and raised the price target from $24 to $25.
  • Erasca, Inc. ERAS jumped 10% to $3.18.
  • Clover Health Investments, Corp. CLOV rose 9.3% to $0.9659.
  • Agenus Inc. AGEN gained 9.1% to $1.7450. Agenus presented complete results for AGEN2373 at 2023 ASCO meeting.
  • ImmunoGen, Inc. IMGN shares gained 5.9% to $15.22 after the company announced that ELAHERE demonstrated 35% reduction in the risk of disease progression or death vs chemotherapy in FRα-Positive platinum-resistant ovarian cancer.


  • Bellerophon Therapeutics, Inc. BLPH shares dipped 85% to $1.06 after the company's Phase 3 REBUILD trial did not meet its primary endpoint.
  • Castle Biosciences, Inc. CSTL fell 48% to $11.80. Baird, SVB Securities and Lake Street lowered their price targets on the stock.
  • Cyxtera Technologies, Inc. CYXT fell 37.2% to $0.10 after the company said, pursuant to the previously disclosed Restructuring Support Agreement it reached with certain of its lenders holding over two-thirds of its outstanding term loan, the Company and certain of its subsidiaries have initiated a pre-arranged court-supervised process under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey.
  • Mallinckrodt plc MNK fell 28.6% to $1.75. Mallinckrodt is considering options including filing for bankruptcy again, according to the Wall Street Journal.
  • Yunji Inc. YJ shares dropped 26.5% to $0.23. Yunji shares jumped over 50% on Friday after the company reported first-quarter financial results.
  • Universal Security Instruments, Inc. UUU dipped 18.3% to $2.45.
  • Context Therapeutics Inc. CNTX fell 18% to $1.0501.
  • EPAM Systems, Inc. EPAM declined 17.7% to $213.50 after the company cut its second-quarter financial outlook.
  • Amyris, Inc. AMRS dropped 16.2% to $0.7885. Amyris initiated strategic transformation program and secured funding to deliver the company's planned cost reduction target of approximately $250 million from cost of goods sold.
  • Comtech Telecommunications Corp. CMTL dropped 13.7% to $10.64.
  • DMC Global Inc. BOOM fell 13.6% to $15.65.
  • SunCar Technology Group Inc. SDA declined 13.2% to $20.22.
  • Elevation Oncology, Inc. ELEV dropped 12.8% to $3.0850. Wedbush maintained Elevation Oncology with an Outperform and raised the price target from $4 to $6.
  • Gannett Co., Inc. GCI fell 12.7% to $1.9650.
  • Zumiez Inc. ZUMZ declined 11.1% to $13.76. Zumiez recently posted a wider-than-expected quarterly loss.
  • IGM Biosciences, Inc. IGMS dropped 10.9% to $12.11. Wedbush reiterated IGM Biosciences with an Outperform and maintained a $37 price target.
  • Endava plc DAVA declined 10.8% to $45.97. Needham reiterated Endava with a Buy and maintained a $68 price target.
  • Bluejay Diagnostics, Inc. BJDX shares fell 10.2% to $0.22 after gaining over 8% on Friday.
  • Cibus, Inc. CBUS dropped 9.6% to $24.40.
  • SHL Telemedicine Ltd. SHLT fell 9.1% to $11.55 after gaining 10% on Friday.
  • Minerva Surgical, Inc. UTRS shares dropped 7.9% to $0.27 after surging over 46% on Friday.
  • Blueprint Medicines Corporation BPMC fell 6.8% to $54.24. SVB Leerink downgraded Blueprint Medicines from Market Perform to Underperform and lowered the price target from $48 to $43.
  • PetMed Express, Inc. PETS declined 5.5% to $14.79.


Now Read This: Bitcoin Falls Below This Major Level; Pepe Becomes Top Loser

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!